Skip to main content
logo
Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
341.12
-25.73 (-7.01%)
At close: Jul 31, 2026, 4:00 PM EDT
340.00
-1.12 (-0.33%)
After-hours: Jul 31, 2026, 7:40 PM EDT

Krystal Biotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
417.3389.13290.5250.7--
Revenue Growth
25.15%33.95%473.02%---
Gross Profit
392.96366.08270.4547.61--
Operating Income
178.64161.365.75-109.62-145.2-68.28
Net Income
225.03204.8389.1610.93-139.98-69.57
Earnings Per Share
7.486.843.000.39-5.49-3.13
EPS Growth
79.81%128.00%669.23%---

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
823.41827.79597.52532.18379.17438.1
Total Debt
9.119.347.268.098.938.02
Net Cash (Debt)
814.29818.45590.26524.08370.24430.07
Net Cash Growth
34.11%38.66%12.63%41.55%-13.91%65.59%
Net Cash Per Share
27.0727.3319.8518.8814.5219.38

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
250.28200.87123.42-88.8-100.57-47.94
Capital Expenditures
-12.9-11.95-4.24-11.8-52.98-68.34
Free Cash Flow
237.38188.91119.18-100.6-153.55-116.27
Free Cash Flow Growth
83.56%58.51%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
94.17%94.08%93.09%93.90%--
Operating Margin
42.81%41.45%22.63%-216.21%--
Pretax Margin
49.68%48.69%32.82%25.44%--
Profit Margin
53.92%52.64%30.69%21.56%--
FCF Margin
56.88%48.55%41.02%-198.43%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
45.6836.0452.22318.10--
Forward PE
42.6534.8933.31---
P/FCF Ratio
42.9238.1037.85---
PS Ratio
24.4118.5015.5369.09--